COVID-19の症例数の増加により、CTスキャナーの需要が高まり、CT市場に好影響を与えると予想されています。例えば、2020年6月、アブダビ健康サービス会社（SEHA）がアラブ首長国連邦でCOVID-19患者の肺炎診断用に16スライスのモバイルCTスキャナーを導入しました。これは、開発途上国がCOVID-19の検出のためにCTスキャナーを使用していることを示しています。「胸部CTの特徴とそのCOVID-19における役割」という記事が2020年6月に発表され、CT検査はCOVID-19患者の診断およびその後の管理において重要な支援の役割を果たしました。CTスキャンはRT-PCR検査における偽陰性結果の可能性を減少させることができます。これらの結果は、COVID-19の間に国内でのCTスキャンの需要を増加させました。世界中の政府はCOVID-19の感染拡大を抑制するための政策措置を採用しており、これがさらにCOVID-19とは無関係な医療画像の需要を減少させています。危機に対処するために病院が取った措置は、安全に行える適切な医療画像の量をさらに減少させています。

2020年の国立衛生研究所の報告によると、心血管疾患への推定投資は2022年に26億2200万米ドルであり、2021年の24億9900万米ドルから大幅に増加しています。CTは心臓や動脈の詳細な画像を迅速に作成します。この検査は冠動脈のプラークの蓄積を診断または検出することができ、心疾患のリスクを判定するため、病気管理におけるCTスキャンの需要が高まっています。市場のプレーヤーは、製品の発売、既存製品のイノベーション、合併・買収といった成長戦略に焦点を当てています。たとえば、2019年3月にシーメンスヘルスケアは、二重ソースと二重検出器技術を備えた製品SOMATOM Forceの発売について米国FDAの承認を受けました。この製品は4Dイメージングと最小限の放射線被ばくを組み合わせています。

• 1 イントロダクション

  • 1.1 調査の前提条件と市場の定義

  • 1.2 本調査の範囲

• 2 調査手法

• 3 エグゼクティブサマリー

• 4 市場力学

  • 4.1 市場概要

  • 4.2 市場の促進要因

    • 4.2.1 高齢者人口の増加と慢性疾患の増加

    • 4.2.2 画像誘導による医療への転換を図る

    • 4.2.3 技術進歩

  • 4.3 市場の抑制要因

    • 4.3.1 十分な診療報酬の欠如

    • 4.3.2 厳格な規制フレームワーク

  • 4.4 ポーターのファイブフォース分析

    • 4.4.1 新規参入の脅威

    • 4.4.2 買い手・消費者の交渉力

    • 4.4.3 サプライヤーの交渉力

    • 4.4.4 代替品の脅威

    • 4.4.5 競合・競争状況の激しさ

• 5 市場セグメンテーション（市場規模別、金額、百万米ドル）

  • 5.1 タイプ別

    • 5.1.1 ロースライス

    • 5.1.2 ミディアムスライス

    • 5.1.3 ハイスライス

  • 5.2 用途別

    • 5.2.1 オンコロジー

    • 5.2.2 神経学

    • 5.2.3 心血管系

    • 5.2.4 筋骨格系

    • 5.2.5 その他の用途

  • 5.3 エンドユーザー別

    • 5.3.1 病院

    • 5.3.2 検診センター

    • 5.3.3 その他のエンドユーザー

  • 5.4 地域別

    • 5.4.1 北米

      • 5.4.1.1 米国
      • 5.4.1.2 カナダ
      • 5.4.1.3 メキシコ

    • 5.4.2 ヨーロッパ

      • 5.4.2.1 ドイツ
      • 5.4.2.2 英国
      • 5.4.2.3 フランス
      • 5.4.2.4 イタリア
      • 5.4.2.5 スペイン
      • 5.4.2.6 その他ヨーロッパ

    • 5.4.3 アジア太平洋

      • 5.4.3.1 中国
      • 5.4.3.2 日本
      • 5.4.3.3 インド
      • 5.4.3.4 オーストラリア
      • 5.4.3.5 韓国
      • 5.4.3.6 その他アジア太平洋

    • 5.4.4 中東・アフリカ

      • 5.4.4.1 GCC地域
      • 5.4.4.2 南アフリカ
      • 5.4.4.3 その他中東・アフリカ

    • 5.4.5 南米

      • 5.4.5.1 ブラジル
      • 5.4.5.2 アルゼンチン
      • 5.4.5.3 その他南米

• 6 競合情勢

  • 6.1 企業プロファイル

    • 6.1.1 Canon Medical Systems Corporation

    • 6.1.2 Fujifilm Holdings Corporation

    • 6.1.3 GE Healthcare

    • 6.1.4 Shimadzu Corporation

    • 6.1.5 Koning Corporation

    • 6.1.6 Koninklijke Philips NV

    • 6.1.7 Neusoft Medical Systems Co. Ltd

    • 6.1.8 Siemens Healthineers

    • 6.1.9 CareStream Health

    • 6.1.10 Planmeca Group (Planmed OY)

    • 6.1.11 Hitachi Healthcare Systems

    • 6.1.12 Stryker Corporation

• 7 市場機会と今後の動向

The computed tomography (CT) market size is expected to be valued at USD 7,565.39 million in 2022, at a projected CAGR of 5.76% during the forecast period.

The increasing number of COVID-19 cases has increased the demand for CT scanners, which is expected to impact the CT market positively. For instance, in June 2020, the Abu Dhabi Health Services Company (SEHA) launched a 16-slice mobile CT scanner in the United Arab Emirates for diagnosing pneumonia in COVID-19 patients, indicating that developing countries are using CT scanners for the detection of COVID-19. As per an article titled ‘Chest CT features and their role in COVID-19’, published in June 2020, CT examination played an important auxiliary role in the diagnosis and subsequent management of COVID-19 patients. CT scans can reduce the chance of false-negative results in the RT-PCR assay. These findings led to increased demand for CT scans in the country during COVID-19. ​Governments worldwide are adopting policy measures to reduce the transmission of COVID-19, which is further decreasing the demand for imaging independent of COVID-19. Measures taken by hospitals for expanding crisis capacity are further reducing the amount of appropriate medical imaging that can be safely performed.​

CT scans are considered the most critical diagnostics tool, especially for lung cancer and traumatic brain injuries. The prevalence of these diseases is boosting the market’s growth. Other market drivers are the rising geriatric population, increasing chronic diseases, shifting medical care toward image-guided interventions, and technological advancements. As per the data published by the American College of Chest Physicians in July 2020, lung cancer is one of the most frequently diagnosed cancers. It accounts for 11.6% of the total cancer cases globally. Worldwide lung cancer incidents are estimated to increase by 38%, to 2.89 million, by 2030. According to the International Osteoporosis Foundation (IOF) 2019, one in three women and one in five men aged 50 years and above sustain osteoporosis-related fractures. Approximately 200 million people are affected by osteoporosis worldwide, resulting in a fracture every three seconds.​ A CT scan provides 3D images of bones and helps in better diagnosis and surgeries for orthopedics. Thus, with the rising burden of orthopedic disorders, the demand for CT scanners is also expected to grow.

Many collaborations, partnerships, and agreements are also taking place in the market. For instance, in December 2020, JSCN Medical Clinic LP and Siemens Healthineers Canada collaborated to open a diagnostic imaging center in Canada. The center will be equipped with magnetic resonance imaging (MRI), computer tomography (CT), X-rays, and ultrasound. Such initiatives by various organizations are expected to influence the market's growth. However, a lack of adequate reimbursement and stringent regulatory framework is expected to hinder the market’s growth.

Key Market Trends

The High Slice Segment Is Expected to Observe a Healthy Growth

High slice scanners include scanners that are more than 128 slices, such as 256, 320, and 640 slices, the highest number of slices. Due to the COVID-19 outbreak, companies are developing new products and ramping up production, as CT scanners are used as a primary tool in many areas. In February 2020, United Imaging donated medical imaging equipment worth USD 1.4 million to hospitals in China. It installed one uCT 780 (160-slice CT scanner) high slice scanner at the Huoshenshan Hospital.​ In April 2020, Canon Medical Systems introduced a deployable 160-slice computed tomography (CT) system integrated with a rapid decontamination tool to improve safety among patients and healthcare professionals.

A High slice CT scanner helps reduce scan time, increase patient throughput, reduce radiation doses, and offers images with more detail and fewer artifacts. It is also preferred for advanced imaging, like in cardiovascular exams. On the other hand, patients with arrhythmias, fast heart rates, obesity, and pediatric patients are better suited for high-slice systems, which are faster and have a larger imaging area. High slice CT is also quicker as no film images need to be developed. Radiologists can further optimize images using computers to detect micro-calcifications that could be missed on low and medium slice CTs.​ Thus, the advantages of high slice CT scanners may boost the market’s growth.

These CT scanners are one of the most advanced, providing 3D images virtually in any patient, including those with cardiac or respiratory conditions, which are more complex than other conditions.​As per the data provided by the British Heart Foundation report in January 2021, cardiovascular and circulatory diseases cause more than 27% of deaths in the United Kingdom, and about 7.6 million people in the country are living with heart diseases.​Therefore, such factors are expected to drive the segment's growth in the future.

North America Accounted for the Largest Share in the Computed Tomography (CT) Market

The North American computed tomography (CT) market holds a significant share globally. In 2020, United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced its plan to deploy readily transportable computed tomography (CT) scanners in the United States to help fight against COVID-19​. Thus, the demand for CT scanners is expected to rise due to the COVID-19 outbreak.

The US market’s growth can be attributed to the rising geriatric population. As the population ages, more cancer cases and chronic diseases are likely to be identified. According to the National Brain Tumor Society, in 2020, about 700,000 people in the United States had a brain tumor, and around 87,000 people are estimated to be diagnosed with it.​ Hence, the rising geriatric population is leading to a growing burden of chronic diseases, which may increase the demand for CT scans and drive the market.

According to the National Institutes of Health 2020 report, the estimated investment for cardiovascular diseases is USD 2,622 million in 2022, a significant increase from the 2021 figures of USD 2,499 million. CT rapidly creates detailed pictures of the heart and its arteries. The test can diagnose or detect plaque build-up in the coronary arteries to determine the risk of heart disease, leading to high demand for CT scans in disease management. ​The market players are focusing on growth strategies, such as product launches, innovations in the existing products, and mergers and acquisitions. For instance, in March 2019, Siemens Healthineers received the US FDA approval to launch its product, SOMATOM Force, which has a dual source and dual detectors technology, coupled with 4D imaging and minimum radiation exposure.

Competitive Landscape

The computed tomography (CT) market is consolidated due to the presence of a few major players, including Canon Medical Systems Corporation, Koninklijke Philips NV, GE Healthcare, and Siemens Healthineers. These major players hold a significant share in the industry. Most of the players focus on bringing technologically advanced products into the market to acquire the maximum market share.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

• 1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition

  • 1.2 Scope of the Study

• 2 RESEARCH METHODOLOGY

• 3 EXECUTIVE SUMMARY

• 4 MARKET DYNAMICS

  • 4.1 Market Overview

  • 4.2 Market Drivers

    • 4.2.1 Rising Geriatric Population and Increasing Incidences of Chronic Diseases

    • 4.2.2 Shifting Medical Care Toward Image-guided Interventions

    • 4.2.3 Technological Advancements

  • 4.3 Market Restraints

    • 4.3.1 Lack of Adequate Reimbursement

    • 4.3.2 Stringent Regulatory Framework

  • 4.4 Porter's Five Forces Analysis

    • 4.4.1 Threat of New Entrants

    • 4.4.2 Bargaining Power of Buyers/Consumers

    • 4.4.3 Bargaining Power of Suppliers

    • 4.4.4 Threat of Substitute Products

    • 4.4.5 Intensity of Competitive Rivalry

• 5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type

    • 5.1.1 Low Slice

    • 5.1.2 Medium Slice

    • 5.1.3 High Slice

  • 5.2 By Application

    • 5.2.1 Oncology

    • 5.2.2 Neurology

    • 5.2.3 Cardiovascular

    • 5.2.4 Musculoskeletal

    • 5.2.5 Other Applications

  • 5.3 By End User

    • 5.3.1 Hospitals

    • 5.3.2 Diagnostic Centers

    • 5.3.3 Other End Users

  • 5.4 By Geography

    • 5.4.1 North America

      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico

    • 5.4.2 Europe

      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe

    • 5.4.3 Asia-Pacific

      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific

    • 5.4.4 Middle-East and Africa

      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa

    • 5.4.5 South America

      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

• 6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles

    • 6.1.1 Canon Medical Systems Corporation

    • 6.1.2 Fujifilm Holdings Corporation

    • 6.1.3 GE Healthcare

    • 6.1.4 Shimadzu Corporation

    • 6.1.5 Koning Corporation

    • 6.1.6 Koninklijke Philips NV

    • 6.1.7 Neusoft Medical Systems Co. Ltd

    • 6.1.8 Siemens Healthineers

    • 6.1.9 CareStream Health

    • 6.1.10 Planmeca Group (Planmed OY)

    • 6.1.11 Hitachi Healthcare Systems

    • 6.1.12 Stryker Corporation

• 7 MARKET OPPORTUNITIES AND FUTURE TRENDS